Medications and Diabetes Risk Quotes

“require chronic or recurrent treatment with a
wide array of medications, some of which could aff ect insulin
sensitivity, �-cell function, or other aspects of glucoregulation. Whenever feasible, preference should be given to those
agents that are either neutral or beneficial in their eff ects on
carbohydrate and lipid metabolism.
In the sections that follow, diff erent classes of medications
will be discussed with regard to their impact on diabetes
risk. These medication classes were selected for discussion
based either on (a) their historical association with dysglycemia in clinical practice, (b) extensive utilization for the
management of comorbid conditions (e.g., hypertension,
dyslipidemia) in diabetic patients, or (c) existing or emerging
reports of possible association with”
― Samuel Dagogo-Jack, Medications and Diabetes Risk: Mechanisms and Approach to Risk Reduction

“Diabetes has been reported in association with exposure
to a wide”
― Samuel Dagogo-Jack, Medications and Diabetes Risk: Mechanisms and Approach to Risk Reduction